Roche ships supplies from Germany to plug UK tests shortfall
Reuters
Published Oct 08, 2020 15:59
Updated Oct 08, 2020 18:35
ZURICH (Reuters) - Swiss drugs and diagnostics group Roche (S:ROG) is shipping supplies from Germany to help Britain's National Health Service (NHS) fill gaps caused by a logistics glitch at a Roche warehouse in southern England, it said on Thursday.
Roche, a main supplier of COVID-19 and other diagnostic tests to the NHS, told UK customers on Wednesday that a switch from an old warehouse to a new automated distribution centre had caused an unforeseen technical issue that hit processing capacity.
"We are confident that the plans we have put in place will deliver significant improvements by the weekend to the supply of the tests affected by these logistical issues," Roche said on Thursday, reiterating its timetable from Wednesday.
"These plans include the introduction of an additional shift in the warehouse and the temporary direct shipment to customers in the UK and Ireland from our warehouse in Mannheim, Germany," a spokesman said by email.
The NHS said on Wednesday it was made aware of a likely shortage of reagent supplied by Roche Diagnostics Ltd caused by issues in its supply chain.
Experts said the supply disruption was affecting a range of tests including for magnesium levels and other materials such as supplies for blood gas analysers which are crucial for the treatment of respiratory illnesses, including COVID-19.
Roche has said the issue affected only the UK and Ireland and that the glitch had not affected its ability to supply COVID-19 tests in the UK.
Roche diabetes care products are not affected as they use a separate warehouse in Bedfordshire, a spokesman said.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.